This expert opinion is intended to support national decision-making by summarising the considerations and concerns of some EU/EEA countries when they discussed whether to introduce the 4CMenB vaccine into their national immunisation programmes.
Immunisation is the only effective method of prevention. Mumps vaccine is given in the form of the combined trivalent measles-mumps-rubella (MMR) vaccine in all European countries with a first dose at or before 18 months of age. The timing of the second dose varies across countries.
This toolkit aims to support infection prevention in schools, with a focus on gastrointestinal diseases, by assisting EU/EEA countries in their communication initiatives for disease prevention in school settings.
This issue of the Communicable Disease Threat Report (CDTR) covers the period 31 July - 6 August 2016 and includes updates on Zika virus, yellow fever in Angola, chikungunya, dengue, West Nile virus and polio.